Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene With Prefrontal Function and Olanzapine Treatment

被引:42
作者
Blasi, Giuseppe [1 ]
De Virgilio, Caterina [2 ]
Papazacharias, Apostolos [1 ]
Taurisano, Paolo [1 ]
Gelao, Barbara [1 ]
Fazio, Leonardo [1 ]
Ursini, Gianluca [1 ]
Sinibaldi, Lorenzo [3 ]
Andriola, Ileana [1 ]
Masellis, Rita [1 ]
Romano, Raffaella [1 ]
Rampino, Antonio [1 ]
Di Giorgio, Annabella [3 ]
Lo Bianco, Luciana [1 ,4 ]
Caforio, Grazia [1 ]
Piva, Francesco [5 ]
Popolizio, Teresa [3 ]
Bellantuono, Cesario [4 ]
Todarello, Orlando [6 ]
Kleinman, Joel E. [7 ]
Gadaleta, Gemma [2 ]
Weinberger, Daniel R. [8 ]
Bertolino, Alessandro [1 ]
机构
[1] Aldo Moro Univ, Grp Psychiat Neurosci, Dept Neurosci & Sense Organs, Bari, Italy
[2] Aldo Moro Univ, Dept Biochem & Mol Biol Ernesto Quagliariello, Bari, Italy
[3] Ist Ricovero & Cura Carattere Sci Casa Sollievo, San Giovanni Rotondo, Italy
[4] Polytech Univ Marche, United Hosp Ancona, Psychiat Unit, Dept Mental Hlth, Ancona, Italy
[5] Polytech Univ Marche, Dept Biochem Biol & Genet, Ancona, Italy
[6] Aldo Moro Univ, Dept Neurosci & Sense Organs, Bari, Italy
[7] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA
[8] Lieber Inst Brain Dev, Baltimore, MD USA
关键词
5-HT2A RECEPTOR; CLINICAL-RESPONSE; HIS452TYR POLYMORPHISM; COGNITIVE IMPAIRMENTS; VAL(158)MET GENOTYPE; T102C POLYMORPHISM; CANDIDATE GENES; HTR2A GENE; SCHIZOPHRENIA; CORTEX;
D O I
10.1001/jamapsychiatry.2013.1378
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IMPORTANCE Serotonin (5-hydroxytryptamine) receptor 2a (5-HT2AR) signaling is important for modulation of corticostriatal pathways and prefrontal activity during cognition. Furthermore, newer antipsychotic drugs target 5-HT2AR. A single-nucleotide polymorphism in the 5-HT2AR gene (HTR2A rs6314, C>T; OMIM 182135) has been weakly associated with differential 5-HT2AR signaling and with physiologic as well as behavioral effects. OBJECTIVE To use a hierarchical approach to determine the functional effects of this single-nucleotide polymorphism on 5-HT2AR messenger RNA and protein expression, on prefrontal phenotypes linked with genetic risk for schizophrenia, and on treatment with olanzapine. DESIGN In silico predictions, in vitro, and case-control investigations. SETTING Academic and clinical facilities. PARTICIPANTS The postmortem study included 112 brains from healthy individuals; the in vivo investigation included a total sample of 371 healthy individuals and patients with schizophrenia. EXPOSURES Patients received olanzapine monotherapy for 8 weeks. MAIN OUTCOMES AND MEASURES In silico predictions, messenger RNA, and protein expression in postmortem human prefrontal cortex and HeLa cells, functional magnetic resonance imaging prefrontal activity and behavior during working memory and attention in healthy individuals, and response to an 8-week trial of olanzapine treatment in patients with schizophrenia. RESULTS Bioinformatic analysis predicted that rs6314 alters patterns of splicing, with possible effects on HTR2A expression. Moreover, the T allele was associated with reduced prefrontal messenger RNA expression in postmortem prefrontal cortex, with reduced protein expression in vitro, inefficient prefrontal blood oxygen level-dependent functional magnetic resonance imaging response during working memory and attentional control processing, and impaired working memory and attention behavior, as well as with attenuated improvement in negative symptoms after olanzapine treatment. CONCLUSIONS AND RELEVANCE Our results suggest that HTR2A rs6314 affects 5-HT2AR expression and functionally contributes to genetic modulation of known endophenotypes of schizophrenia-like higher-level cognitive behaviors and related prefrontal activity, as well as response to treatment with olanzapine.
引用
收藏
页码:921 / 930
页数:10
相关论文
共 76 条
[1]   Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia [J].
Abdolmaleky, HM ;
Faraone, SV ;
Glatt, SJ ;
Tsuang, MT .
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) :53-62
[2]   Alterations of serotonin transmission in schizophrenia [J].
Abi-Dargham, Anissa .
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 :133-164
[3]  
Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4
[4]  
1-0
[5]  
FT518
[6]  
Arranz MJ, 1996, NEUROSCI LETT, V217, P177, DOI 10.1016/0304-3940(96)13094-9
[7]   Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine [J].
Arranz, MJ ;
Munro, J ;
Owen, MJ ;
Spurlock, G ;
Sham, PC ;
Zhao, J ;
Kirov, G ;
Collier, DA ;
Kerwin, RW .
MOLECULAR PSYCHIATRY, 1998, 3 (01) :61-66
[8]   Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction [J].
Ayalew, M. ;
Le-Niculescu, H. ;
Levey, D. F. ;
Jain, N. ;
Changala, B. ;
Patel, S. D. ;
Winiger, E. ;
Breier, A. ;
Shekhar, A. ;
Amdur, R. ;
Koller, D. ;
Nurnberger, J. I. ;
Corvin, A. ;
Geyer, M. ;
Tsuang, M. T. ;
Salomon, D. ;
Schork, N. J. ;
Fanous, A. H. ;
O'Donovan, M. C. ;
Niculescu, A. B. .
MOLECULAR PSYCHIATRY, 2012, 17 (09) :887-905
[9]   Interaction of COMT Val108/158 met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia [J].
Bertolino, A ;
Caforio, G ;
Blasi, G ;
De Candia, M ;
Latorre, V ;
Petruzzella, V ;
Altamura, M ;
Nappi, G ;
Papa, S ;
Callicott, JH ;
Mattay, VS ;
Bellomo, A ;
Scarabino, T ;
Weinberger, DR ;
Nardini, M .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (10) :1798-1805
[10]   THE GENETICS OF SCHIZOPHRENIA [J].
Bertolino, A. ;
Blasi, G. .
NEUROSCIENCE, 2009, 164 (01) :288-299